Welcome to "Oncology Marketing Goes Prime Time,"

 the latest e-Book by MM&M


Ten years ago the direct advertising of cancer drugs to consumers was unheard of. Now you'll find ads for Keytrudea and Opdivo on prime-time TV.

Bristol-Myers Squibb doled out nearly $170 million on it Opdivo campaign in 2016. Merck came in second at more than $61 million.

To explore the oncology marketing landscape, MM&M looks at the marketing efforts of several of the largest pharma oncology brands. Inside this e-Book we examine the top five cancer drugs in marketing spend.



Free to download:

It’s free to download, just fill out our form below. Enjoy!

* Required Fields

You'll also read about:

  • Why pharma brands are turning to DTC advertising to promote their oncology products
  • What are some of the next cancer drugs on the horizon
  • How Provenge's comeback proves marketing's impact
  • How the oncology marketing paradigm is changing

 Be sure to access this FREE e-Book today! 


Fix the following errors: